Abstract
Current interest in antimicrobial susceptibility testing of anaerobic pathogens and recent recognition that actinomycetes other than Actinomyces israelii may cause actinomycosis in man prompted this in vitro survey of 74 strains of actinomycetes, representing seven species. Minimum inhibitory concentrations (MICs) for 24 antimicrobials were determined by inhibition of gross colonial enlargement in semisolid antibiotic agar after incubation at 37 C for 48 h under anaerobic conditions. Erythromycin and rifampin were the most active drugs in vitro (MICs of 0.008 to 0.25 μg/ml), although a small number of non-israelii strains were conspicuously more resistant to the latter (MICs >0.5 μg/ml). Penicillin G, cephaloridine, minocycline, and clindamycin were also very active in vitro (MICs of 0.03 to 1.0 μg/ml); for a few non-israelii strains the MICs of clindamycin were 2.0 to 8.0 μg/ml. MICs of cephalothin, ampicillin, lincomycin, tetracycline, doxycycline, and chloramphenicol were well within a therapeutic range for all strains of A. israelii and most other species, although the MIC of lincomycin against a few non-israelii strains and of tetracycline and doxycycline against the majority of these strains was 2.0 to 8.0 μg/ml. Oxacillin, dicloxacillin, and cephalexin were less active in vitro, particularly against strains other than A. israelii. Most non-israelii species were not suppressed by 125 μg of metronidazole per ml, which concentration inhibited all strains of A. israelii; otherwise, there were no antimicrobial susceptibility differences among the species tested. Aminoglycoside activity was negligible.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLAKE G. C. SENSITIVITIES OF COLONIES AND SUSPENSIONS OF ACTINOMYCES ISRAELII TO PENICILLINS, TETRACYCLINES, AND ERYTHROMYCIN. Br Med J. 1964 Jan 18;1(5376):145–148. doi: 10.1136/bmj.1.5376.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BUCHANAN B. B., PINE L. Characterization of a propionic acid producing actinomycete, Actinomyces propionicus, sp. nov. J Gen Microbiol. 1962 Jun;28:305–323. doi: 10.1099/00221287-28-2-305. [DOI] [PubMed] [Google Scholar]
- Boand A., Novak M. SENSITIVITY CHANGES OF ACTINOMYCES BOVIS TO PENICILLIN AND STREPTOMYCIN. J Bacteriol. 1949 May;57(5):501–508. doi: 10.1128/jb.57.5.501-508.1949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brock D. W., Georg L. K., Brown J. M., Hicklin M. D. Actinomycosis caused by Arachnia propionica: report of 11 cases. Am J Clin Pathol. 1973 Jan;59(1):66–77. doi: 10.1093/ajcp/59.1.66. [DOI] [PubMed] [Google Scholar]
- COSTIGAN P. G. A case of actinomycosis treated with streptomycin. Can Med Assoc J. 1947 Apr;56(4):431–431. [PMC free article] [PubMed] [Google Scholar]
- Caldwell J. L., Jr Actinomycosis treated with cephalothin. South Med J. 1971 Aug;64(8):987–passim. doi: 10.1097/00007611-197108000-00018. [DOI] [PubMed] [Google Scholar]
- Coleman R. M., Georg L. K., Rozzell A. R. Actinomyces naeslundii as an agent of human actinomycosis. Appl Microbiol. 1969 Sep;18(3):420–426. doi: 10.1128/am.18.3.420-426.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J., Scholand J. F., Hodges G. R., Saslaw S. Clindamycin in the treatment of serious anaerobic infections. Ann Intern Med. 1973 Jun;78(6):853–859. doi: 10.7326/0003-4819-78-6-853. [DOI] [PubMed] [Google Scholar]
- GARROD L. P. Actinomycosis of the lung; aetiology, diagnosis and chemotherapy. Tubercle. 1952 Sep;33(9):258–266. doi: 10.1016/s0041-3879(52)80124-2. [DOI] [PubMed] [Google Scholar]
- GARROD L. P. The sensitivity of actinomyces israeli to antibiotics. Br Med J. 1952 Jun 14;1(4771):1263–1264. doi: 10.1136/bmj.1.4771.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GEISTER R. S., MEYER E. The effect of aureomycin and penicillin on experimental actinomycosis infections in mice. J Lab Clin Med. 1951 Jul;38(1):101–111. [PubMed] [Google Scholar]
- GEORG L. K., ROBERTSTAD G. W., BRINKMAN S. A., HICKLIN M. D. A NEW PATHOGENIC ANAEROBIC ACTINOYCES SPECIES. J Infect Dis. 1965 Feb;115:88–99. doi: 10.1093/infdis/115.1.88. [DOI] [PubMed] [Google Scholar]
- GEORG L. K., ROBERTSTAD G. W., BRINKMAN S. A. IDENTIFICATION OF SPECIES OF ACTINOMYCES. J Bacteriol. 1964 Aug;88:477–490. doi: 10.1128/jb.88.2.477-490.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GREENE L. W., BLACK W. C. Treatment of cervico-facial actinomycosis with isoniazid. Rocky Mt Med J. 1955 Jan;52(1):43–46. [PubMed] [Google Scholar]
- Gerencser M. A., Slack J. M. Identification of human strains of Actinomyces viscosus. Appl Microbiol. 1969 Jul;18(1):80–87. doi: 10.1128/am.18.1.80-87.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HERRELL W. E., BALOWS A., DAILEY J. S. Erythromycin in the treatment of actinomycosis. Antibiotic Med Clin Ther (New York) 1955 Sep;1(9):507–512. [PubMed] [Google Scholar]
- Kuhn R. E., Vaughn R. T., Herbst G. A. The effect of BCG on the course of experimental Chagas' disease in mice. Int J Parasitol. 1975 Oct;5(5):557–560. doi: 10.1016/0020-7519(75)90049-1. [DOI] [PubMed] [Google Scholar]
- LANE S. L., KUTSCHER A. H., CHAVES R. Oxytetracycline in the treatment of orocervical facial actinomycosis; report of seven cases. J Am Med Assoc. 1953 Mar 21;151(12):986–988. [PubMed] [Google Scholar]
- LITTMAN M. L., PHILLIPS G. E., FUSILLO M. H. In vitro susceptibility of human pathogenic actinomycetes to chloramphenicol (chloromycetin). Am J Clin Pathol. 1950 Nov;20(11):1076–1078. doi: 10.1093/ajcp/20.11_ts.1076. [DOI] [PubMed] [Google Scholar]
- Lerner P. I. Susceptibility of Actinomyces species to lincomycin and its 7-halogenated analogues. Antimicrob Agents Chemother (Bethesda) 1968;8:461–464. [PubMed] [Google Scholar]
- Lerner P. I. Susceptibility of Actinomyces to cephalosporins and lincomycin. Antimicrob Agents Chemother (Bethesda) 1967;7:730–735. doi: 10.1128/AAC.7.6.730. [DOI] [PubMed] [Google Scholar]
- MCVAY L. V., Jr, SPRUNT D. H. A long term evaluation of aureomycin in the treatment of actinomycosis. Ann Intern Med. 1953 May;38(5):955–966. doi: 10.7326/0003-4819-38-5-955. [DOI] [PubMed] [Google Scholar]
- MCVAY L. V., Jr, SPRUNT D. H. Treatment of actinomycosis with isoniazid. J Am Med Assoc. 1953 Sep 12;153(2):95–98. doi: 10.1001/jama.1953.02940190021005. [DOI] [PubMed] [Google Scholar]
- Mohr J. A., Rhoades E. R., Muchmore H. G. Actinomycosis treated with lincomycin. JAMA. 1970 Jun 29;212(13):2260–2262. [PubMed] [Google Scholar]
- PEABODY J. W., Jr, SEABURY J. H. Actinomycosis and nocardiosis. A review of basic differences in therapy. Am J Med. 1960 Jan;28:99–115. doi: 10.1016/0002-9343(60)90226-6. [DOI] [PubMed] [Google Scholar]
- Rose H. D., Rytel M. W. Actinomycosis treated with clindamycin. JAMA. 1972 Aug 28;221(9):1052–1052. [PubMed] [Google Scholar]
- STRAUSS R. E., KLIGMAN A. M., PILLSBURY D. M. The chemotherapy of actinomycosis and nocardiosis. Am Rev Tuberc. 1951 Apr;63(4):441–448. doi: 10.1164/art.1951.63.4.441. [DOI] [PubMed] [Google Scholar]
- Slack J. M., Gerencser M. A. Two new serological groups of Actinomyces. J Bacteriol. 1970 Jul;103(1):265–266. doi: 10.1128/jb.103.1.265-266.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Speir W. A., Jr, Mitchener J. W., Galloway R. F. Primary pulmonary botryomycosis. Chest. 1971 Jul;60(1):92–93. doi: 10.1378/chest.60.1.92. [DOI] [PubMed] [Google Scholar]
- Tally F. P., Sutter V. L., Finegold S. M. Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med. 1972 Dec;117(6):22–26. [PMC free article] [PubMed] [Google Scholar]